What is Gilead Sciences's other accrued liabilities?

Gilead Sciences (GILD) reported other accrued liabilities of $3.40B in Q1 2026.

What does other accrued liabilities mean?

Miscellaneous short-term debts that do not fit into standard categories like accounts payable.

Gilead Sciences Other accrued liabilities decreased by 14.0% to $3.40B in Q1 2026 compared to the prior quarter.

StatementBalance Sheet Statement

SectionCurrent Liabilities

CategoryOther

SignalContext dependent

VolatilityStable

First reportedQ3 2025

Last reportedQ1 2026

Significant changes should be analyzed to determine if they represent one-time adjustments or shifts in operational expense timing.

This represents miscellaneous short-term obligations that do not fall into standard categories like accounts payable or...

Standard residual category; peers report this as other current liabilities.

Metric ID: current_liabilities_other_liabilities_current

2 periods

	Q4 '25	Q1 '26
Value	$3.95B	$3.40B
QoQ Change	—	-14.0%

Range$3.40B – $3.95B

What is Gilead Sciences's other accrued liabilities?: Gilead Sciences (GILD) reported other accrued liabilities of $3.40B in Q1 2026.
What does other accrued liabilities mean?: Miscellaneous short-term debts that do not fit into standard categories like accounts payable.